Detalhe da pesquisa
1.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Haematologica
; 104(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171024
2.
Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
Strahlenther Onkol
; 193(2): 116-124, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27316376
3.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
4.
Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.
Haematologica
; 100(7): e269-71, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840598
5.
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Leuk Lymphoma
; 55(8): 1854-60, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24206091